Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06127654Phase 3Not Yet Recruiting

Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy

Role: collaborator

NCT04394182Not ApplicableSuspended

Ultra Low Doses of Therapy With Radiation Applicated to COVID-19

Role: lead

NCT04424628Not ApplicableUnknown

Radiotherapy 3 vs 6 Gy in Gonarthrosis and Coxarthrosis

Role: lead

All 3 trials loaded